Imatinib Recruiting Phase 2 Trials for Chronic Myeloid Leukemia (CML) / Philadelphia Chromosome Positive CML Treatment

RecruitingTreatment2 IdentifierTitleDrugs
NCT03906292Frontline Asciminib Combination in Chronic Phase CML
NCT03193281KISS Study: Kinase Inhibition With Sprycel Start up
NCT03241199The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia
NCT02001818Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia